This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through February 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
medical: Archive
Top Stock Reports for NVIDIA, Amazon & Regeneron
by Mark Vickery
NVDA headlines Zacks Research Daily as AI-driven data center growth powers outlook, while Amazon and Regeneron show mixed but resilient trends.
AMZNNegative Net Change REGNPositive Net Change NVDANegative Net Change RMDPositive Net Change TDGNegative Net Change NPKPositive Net Change EQNRPositive Net Change AXILPositive Net Change
computers consumer-staples finance medical multi-sector-conglomerates semiconductor
Baxter to Post Q4 Earnings: What's in Store for the Stock?
by Zacks Equity Research
BAX's fourth-quarter results are likely to reflect muted revenue growth and an EPS decline due to ongoing infusion therapy and IV fluid headwinds.
BAXPositive Net Change MASINegative Net Change DXCMPositive Net Change MMSIPositive Net Change
medical medical-devices
Here's Why You Should Retain CONMED Stock in Your Portfolio for Now
by Zacks Equity Research
CNMD's growth rests on AirSeal, Buffalo Filter and BioBrace as supply chains normalize, even as tariffs and a GI exit pressure EPS.
CNMDPositive Net Change ISRGPositive Net Change ALGNPositive Net Change CAHPositive Net Change
medical medical-devices
ECL Stock Falls in Pre-Market Despite Q4 Earnings Beat, Margins Expand
by Zacks Equity Research
Ecolab posts strong Q4 earnings with margin expansion and solid segment growth, but cautious sentiment persists despite gains in water, pest and life sciences.
ECLNegative Net Change DVANegative Net Change CAHPositive Net Change DOCSPositive Net Change
earnings medical medical-devices
Will Lower Patient Days Affect Tenet Healthcare's Q4 Earnings?
by Zacks Equity Research
THC heads into Q4 earnings with solid expected revenue and admissions growth, but a sharp drop in hospital patient days could cloud the bottom-line outlook.
THCNegative Net Change HCAPositive Net Change ENSGNegative Net Change EHCNegative Net Change
earnings medical
GEHC Launches ReadyFix Fleet Management to Boost ECG Efficiency
by Zacks Equity Research
GE HealthCare launches ReadyFix in the United States, a remote fleet management tool for MAC VU360 ECGs to boost device uptime and efficiency across hospitals.
ISRGPositive Net Change ATRCPositive Net Change VCYTPositive Net Change GEHCPositive Net Change
medical medical-devices
CVS Beats on Q4 Earnings and Revenues but Shares Slide in Pre-Market
by Zacks Equity Research
CVS beats Q4 earnings and revenue estimates, but higher costs squeeze margins. Shares slip pre-market despite upbeat 2026 EPS guidance.
RMDPositive Net Change CVSPositive Net Change EYEPositive Net Change NVSTPositive Net Change
earnings medical medical-devices
Will DXCM Deliver Q4 Earnings Beat on G7 Stabilization, Volume Growth?
by Zacks Equity Research
DexCom heads into Q4 earnings with easing G7 issues, improving supply chains and rebounding U.S. new customer starts lifting revenue outlook.
MASINegative Net Change DXCMPositive Net Change MMSIPositive Net Change VCYTPositive Net Change
medical medical-devices
ZBH Q4 Earnings & Revenues Top Estimates, Stock Up in Pre-Market
by Zacks Equity Research
Zimmer Biomet beats Q4 earnings and revenue estimates, with sales up 10.9% and shares rising 1.4% pre-market despite margin contraction.
RMDPositive Net Change ZBHPositive Net Change EYEPositive Net Change NVSTPositive Net Change
earnings medical
LLY Expands Cell Therapy Ambitions With $2.4B Orna Therapeutics Deal
by Zacks Equity Research
Eli Lilly is set to buy Orna Therapeutics for $2.4B to expand in vivo CAR-T and circular RNA capabilities, signaling a long-term push to diversify its pipeline.
MRKPositive Net Change LLYPositive Net Change VRTXPositive Net Change
biotechs cell-therapy medical pharmaceuticals